Disrupt Therapeutics
Biotechnology Research • 
Spain • 1-10 Employees
Company overview
| Headquarters | Spain |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
Key Contact at Disrupt Therapeutics
David Andreu
Co-Founder; peptide drug specialist
About Disrupt Therapeutics
Disrupt Therapeutics S.L., founded in Barcelona in 2023, is a pioneering biotech company focused on the preclinical and clinical development of a groundbreaking peptide-based drug. This novel therapeutic agent aims to counteract the harmful effects of cannabinoids, offering a solution for cannabis addiction while also mitigating the side effects experienced by chronic pain patients using medical cannabis.
$
Disrupt Therapeutics revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
Disrupt Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Australia
United States
United Kingdom
Switzerland
Netherlands
FranceFrequently asked questions
Disrupt Therapeutics is located in ES.
Disrupt Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
